| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,904 |
4,680 |
$168K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,749 |
1,925 |
$150K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,041 |
628 |
$37K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
705 |
603 |
$29K |
| 93000 |
|
4,511 |
3,107 |
$27K |
| 93015 |
|
1,001 |
605 |
$24K |
| J2785 |
Injection, regadenoson, 0.1 mg |
750 |
430 |
$22K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
870 |
497 |
$21K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,102 |
749 |
$20K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
602 |
209 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
511 |
291 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
511 |
291 |
$4K |
| 93880 |
|
110 |
67 |
$4K |
| 93925 |
|
160 |
96 |
$4K |
| 93268 |
|
19 |
16 |
$2K |
| 93970 |
|
51 |
28 |
$1K |
| 93923 |
|
24 |
14 |
$514.26 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$306.12 |
| 99152 |
|
63 |
38 |
$240.80 |
| 99153 |
Mod sedat endo service >5yrs |
27 |
14 |
$20.37 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
2,655 |
2,309 |
$0.00 |
| 1111F |
|
688 |
657 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
563 |
487 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
244 |
189 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
87 |
65 |
$0.00 |
| G8967 |
Fda approved oral anticoagulant is prescribed |
24 |
24 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
87 |
65 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
3,507 |
3,158 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
2,094 |
1,845 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
279 |
263 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,993 |
2,619 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
456 |
347 |
$0.00 |
| 1100F |
|
683 |
571 |
$0.00 |
| 3288F |
|
479 |
443 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
735 |
654 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
30 |
27 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
70 |
48 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
165 |
156 |
$0.00 |
| 4004F |
|
13 |
13 |
$0.00 |
| G8539 |
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment |
13 |
13 |
$0.00 |